Austar Lifesciences Limited
HKEX:6118.HK
0.64 (HKD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2024 Q2 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | 2018 Q4 | 2018 Q2 | 2017 Q4 | 2017 Q2 | 2016 Q4 | 2016 Q2 | 2015 Q4 | 2015 Q2 | 2014 Q4 | 2014 Q2 | 2013 Q4 | 2013 Q2 | 2012 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 700.919 | 919.457 | 1,124.664 | 1,103.98 | 1,159.652 | 855.376 | 777.995 | 517.985 | 571.235 | 477.786 | 488.111 | 328.474 | 302.081 | 244.852 | 382.708 | 289.837 | 334.458 | 293.086 | 358.927 | 320.823 | 351.083 | 354.07 | 176.288 |
| Cost of Revenue
| 555.502 | 732.524 | 897.73 | 868.245 | 904.959 | 631.061 | 592.323 | 380.127 | 413.977 | 350.8 | 369.659 | 242.532 | 226.052 | 199.349 | 296.573 | 216.265 | 260.952 | 212.345 | 244.057 | 207.086 | 246.925 | 243.262 | 122.547 |
| Gross Profit
| 145.417 | 186.933 | 226.934 | 235.735 | 254.693 | 224.315 | 185.672 | 137.858 | 157.258 | 126.986 | 118.452 | 85.942 | 76.029 | 45.503 | 86.135 | 73.572 | 73.506 | 80.741 | 114.87 | 113.737 | 104.158 | 110.808 | 53.742 |
| Gross Profit Ratio
| 0.207 | 0.203 | 0.202 | 0.214 | 0.22 | 0.262 | 0.239 | 0.266 | 0.275 | 0.266 | 0.243 | 0.262 | 0.252 | 0.186 | 0.225 | 0.254 | 0.22 | 0.275 | 0.32 | 0.355 | 0.297 | 0.313 | 0.305 |
| Reseach & Development Expenses
| 23.468 | 27.465 | 36.829 | 33.334 | 38.857 | 26.741 | 25.72 | 22.548 | 22.484 | 20.093 | 16.255 | 14.053 | 13.665 | 12.397 | 15.489 | 16.552 | 14.736 | 12.172 | 13.403 | 10.191 | 13.985 | 9.912 | 5.974 |
| General & Administrative Expenses
| 51.209 | 80.151 | 66.802 | 67.812 | 66.991 | 61.103 | 52.418 | 46.277 | 54.053 | 54.678 | 41.795 | 35.655 | 41.813 | 28.983 | 36.18 | 31.773 | 30.21 | 26.003 | 26.71 | 30.568 | 28.336 | 19.513 | 11.962 |
| Selling & Marketing Expenses
| 63.937 | 92.191 | 94.882 | 83.777 | 86.088 | 84.201 | 87.027 | 61.665 | 78.743 | 58.334 | 61.32 | 44.315 | 59.747 | 40.726 | 42.524 | 40.163 | 38.844 | 32.158 | 32.76 | 32.374 | 41.476 | 30.628 | 18.026 |
| SG&A
| 112.846 | 177.821 | 158.091 | 152.03 | 151.904 | 152.172 | 151.38 | 107.942 | 137.936 | 113.012 | 103.115 | 79.97 | 101.71 | 69.709 | 78.854 | 71.936 | 69.054 | 58.161 | 59.47 | 62.942 | 69.812 | 50.141 | 29.988 |
| Other Expenses
| -8.151 | -12.844 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.524 | -0.283 | -0.283 |
| Operating Expenses
| 128.163 | 192.442 | 183.316 | 184.894 | 185.475 | 28.623 | 161.693 | 120.67 | 153.575 | 120.815 | 113.193 | 91.331 | 108.952 | 74.109 | 92.198 | 88.01 | 80.188 | 67.88 | 69.928 | 70.281 | 76.971 | 61.693 | 35.68 |
| Operating Income
| 17.254 | -5.509 | 37.811 | 52.581 | 67.727 | 49.241 | 13.436 | 12.945 | 1.789 | 0.862 | 0.335 | -6.35 | -33.902 | -34.218 | -6.851 | -13.682 | -7.465 | 11.999 | 43.753 | 40.901 | 25.944 | 45.944 | 19.5 |
| Operating Income Ratio
| 0.025 | -0.006 | 0.034 | 0.048 | 0.058 | 0.058 | 0.017 | 0.025 | 0.003 | 0.002 | 0.001 | -0.019 | -0.112 | -0.14 | -0.018 | -0.047 | -0.022 | 0.041 | 0.122 | 0.127 | 0.074 | 0.13 | 0.111 |
| Total Other Income Expenses Net
| -8.068 | -0.885 | 0.44 | -4.347 | -0.386 | 202.643 | 9.838 | 5.27 | 2.867 | 6.69 | 7.102 | 2.411 | 2.376 | 7.324 | 2.248 | 0.784 | 1.671 | 1.385 | 0.618 | 2.553 | 1.71 | 3.055 | -0.337 |
| Income Before Tax
| 9.186 | -6.394 | 38.251 | 48.234 | 67.341 | 251.884 | 23.274 | 18.215 | 4.656 | 7.552 | 7.437 | -3.939 | -31.526 | -26.894 | -4.603 | -12.898 | -5.794 | 13.384 | 44.371 | 43.454 | 27.654 | 48.999 | 19.163 |
| Income Before Tax Ratio
| 0.013 | -0.007 | 0.034 | 0.044 | 0.058 | 0.294 | 0.03 | 0.035 | 0.008 | 0.016 | 0.015 | -0.012 | -0.104 | -0.11 | -0.012 | -0.045 | -0.017 | 0.046 | 0.124 | 0.135 | 0.079 | 0.138 | 0.109 |
| Income Tax Expense
| 4.997 | 1.939 | 7.171 | 11.57 | 11.764 | 34.837 | 4.151 | 5.733 | 1.337 | 3.407 | 3.607 | 0.229 | 2.426 | 1.797 | 1.941 | 0.772 | 2.033 | 3.24 | 11.927 | 10.705 | 9.696 | 13.386 | 5.771 |
| Net Income
| 5.877 | -39.944 | 41.618 | 45.843 | 59.43 | 217.87 | 20.318 | 12.782 | 3.922 | 4.169 | 3.832 | -3.725 | -28.988 | -25.097 | -6.544 | -12.126 | -3.761 | 10.145 | 32.443 | 32.75 | 17.958 | 35.613 | 13.393 |
| Net Income Ratio
| 0.008 | -0.043 | 0.037 | 0.042 | 0.051 | 0.255 | 0.026 | 0.025 | 0.007 | 0.009 | 0.008 | -0.011 | -0.096 | -0.102 | -0.017 | -0.042 | -0.011 | 0.035 | 0.09 | 0.102 | 0.051 | 0.101 | 0.076 |
| EPS
| 0.012 | -0.077 | 0.08 | 0.089 | 0.11 | 0.43 | 0.04 | 0.02 | 0.008 | 0.008 | 0.008 | -0.01 | -0.06 | -0.05 | -0.013 | -0.024 | -0.01 | 0.02 | 0.078 | 0.087 | 0.045 | 0.095 | 0.036 |
| EPS Diluted
| 0.012 | -0.078 | 0.081 | 0.089 | 0.12 | 0.43 | 0.04 | 0.025 | 0.008 | 0.008 | 0.008 | -0.007 | -0.057 | -0.049 | -0.013 | -0.024 | -0.007 | 0.02 | 0.078 | 0.087 | 0.048 | 0.095 | 0.036 |
| EBITDA
| 28.607 | 10.248 | 47.196 | 58.874 | 74.714 | 55.907 | 20.698 | 19.132 | 8.027 | 6.373 | 3.885 | -2.327 | -30.297 | -29.909 | -0.633 | -9.024 | -2.125 | 16.609 | 47.042 | 44.928 | 29.043 | 48.56 | 21.027 |
| EBITDA Ratio
| 0.041 | 0.011 | 0.042 | 0.053 | 0.064 | 0.065 | 0.027 | 0.037 | 0.014 | 0.013 | 0.008 | -0.007 | -0.1 | -0.122 | -0.002 | -0.031 | -0.006 | 0.057 | 0.131 | 0.14 | 0.083 | 0.137 | 0.119 |